Cardiovascular and Circulatory System Atherosclerosis or Coronary Artery Disease

Table of Contents

RECENT HIGHLIGHTS AND CHANGES
--Recent Highlights and Changes
UPCOMING PATENT EXPIRES BY THERAPY AREA
Atherosclerosis or Coronary Artery Disease Pipeline Overview
--% of Projects (By Phase of Development)
--No. of Projects by Phase of Development
--Marketed Products Vs. Pipeline Products
Company Overview - Pipeline Projects
--Company Overview - Pipeline Projects

--Top Companies in late stage Atherosclerosis or Coronary Artery Disease Projects
--ActivBiotics
--erly Merlin Technologies, Inc.)
--Abbott Laboratories
--Anthera Pharmaceuticals, Inc.
--Angiotech Pharmaceuticals Inc
--AsiaPharm Group Ltd.
--Arvind Remedies Ltd
--BioCardia, Inc.
--Baxter International Inc
--Genzyme Corporation
--Biomedica foscama
--Merck & Co Inc
--GlaxoSmithKline plc
--Nissan Chemical Industries, Ltd.
--Millennium Pharmaceuticals Inc
--Regeneron Pharmaceuticals Inc
--Pfizer Inc
--Taisho Pharmaceutical Co., Ltd.
--Sunway Biotech Co.Ltd.
--TheraVitae Ltd.
--Takeda Pharmaceutical Company Limited

--Top Companies in early stage Atherosclerosis or Coronary Artery Disease Projects
--Ardana plc
--Abbott Laboratories
--Bristol-Myers Squibb Company
--BioInvent International AB
--CliniGenetics SA
--Chronogen
--CytRx Corporation
--CV Therapeutics Inc
--Exelixis Inc
--Dr Reddys Laboratories Ltd
--Genfit
--Genentech Inc
--Liponex Inc.
--GlaxoSmithKline plc
--Miravant Medical Technologies
--Merck & Co Inc
--Phosphagenics Ltd.
--Pfizer Inc
--Wyeth
--Trigen Holdings AG

Pipeline Revenue
--Pipeline Revenue
Full Pipeline View
--Pre Clinical Pipeline View
--Phase I Pipeline View
--Phase II Pipeline View
--Phase III Pipeline View
--Pending Approval Pipeline View
--On the Market Pipeline View
--Discovery/Development Pipeline View